Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Off-label prescribing during pregnancy

W F Rayburn1, K C Farmer

  • 1Department of Obstetrics and Gynecology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Obstetrics and Gynecology Clinics of North America
|September 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Envenomations during pregnancy reported to the national poison data system, 2009-2018.

Toxicon : official journal of the International Society on Toxinology·2020
Same author

The obstetric consultant on the labour ward: beyond infancy to early adolescence.

BJOG : an international journal of obstetrics and gynaecology·2017
Same author

HIV Pharmacist's Impact on Inpatient Antiretroviral Errors.

HIV medicine·2016
Same author

The first 1000 patients on an internet-based colorectal neoplasia database across private and public medicine in Australia: development of a binational model for the Colorectal Surgical Society of Australia and New Zealand.

Diseases of the colon and rectum·2014
Same author

First-trimester hyperglycosylated human chorionic gonadotropin and development of hypertension.

Prenatal diagnosis·2013
Same author

Management of envenomations during pregnancy.

Clinical toxicology (Philadelphia, Pa.)·2013

Obstetricians often use medications for unapproved pregnancy uses, such as preventing preterm labor or preeclampsia. This practice is legally permissible if supported by scientific evidence and patient consent.

Area of Science:

  • Obstetrics and Gynecology
  • Pharmacology

Background:

  • Off-label drug prescribing is common in obstetrics for various indications.
  • Reasons include preventing pregnancy complications like premature labor, preeclampsia, and fetal infections.
  • Legal and ethical considerations surround off-label use during pregnancy.

Purpose of the Study:

  • To review the rationale and justification for off-label drug prescribing in obstetric practice.
  • To discuss the legal standing and evidence requirements for such prescribing.
  • To emphasize patient communication and documentation standards.

Main Methods:

  • Review of existing literature and clinical guidelines on off-label prescribing in pregnancy.
  • Analysis of legal precedents and ethical considerations for physician prescribing practices.

Related Experiment Videos

  • Discussion of evidence-based justification and patient informed consent.

    • Main Results:

    • Physicians have a legal right to prescribe off-label if based on sound scientific evidence.
    • Performing well-controlled studies during pregnancy is challenging, necessitating alternative justification methods.
    • Widespread use and consensus among clinicians can support off-label prescribing.
    • Informed patient consent and clear documentation are crucial.

    Conclusions:

    • Off-label drug use in obstetrics is a common and often necessary practice.
    • Justification relies on scientific evidence, clinical consensus, and patient understanding.
    • Thorough documentation of patient discussions regarding risks and benefits is essential.